Association of gut dysbiosis with first‑episode psychosis (Review)
- Authors:
- Christos Theleritis
- Maria-Ioanna Stefanou
- Marina Demetriou
- Evangelos Alevyzakis
- Konstantinos Triantafyllou
- Nikolaos Smyrnis
- Demetrios A. Spandidos
- Emmanouil Rizos
-
Affiliations: Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece, Second Department of Neurology, School of Medicine, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece, Hepatogastroenterology Unit, Second Department of Propaedeutic Internal Medicine, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece, Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece - Published online on: May 24, 2024 https://doi.org/10.3892/mmr.2024.13254
- Article Number: 130
-
Copyright: © Theleritis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Nguyen TT, Kosciolek T, Eyler LT, Knight R and Jeste DV: Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res. 99:50–61. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Van Ameringen M, Turna J, Patterson B, Pipe A, Mao RQ, Anglin R and Surette MG: The gut microbiome in psychiatry: A primer for clinicians. Depress Anxiety. 36:1004–1025. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu JCW, Gorbovskaya I, Hahn MK and Müller DJ: The gut microbiome in schizophrenia and the potential benefits of prebiotic and probiotic treatment. Nutrients. 13:11522021. View Article : Google Scholar : PubMed/NCBI | |
|
Gómez-Eguílaz M, Ramón-Trapero JL, Pérez-Martínez L and Blanco JR: The microbiota-gut-brain axis and its large projections. Rev Neurol. 68:111–117. 2019.(In Spanish). PubMed/NCBI | |
|
Strandwitz P: Neurotransmitter modulation by the gut microbiota. Brain Res. 1693:128–133. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Xu J and Chen Y: Regulation of Neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 13:20992021. View Article : Google Scholar : PubMed/NCBI | |
|
Stopińska K, Radziwoń-Zaleska M and Domitrz I: The microbiota gut-brain axis as a key to neuropsychiatric disorders: A mini review. J Clin Med. 10:46402021. View Article : Google Scholar : PubMed/NCBI | |
|
Michel L and Prat A: One more role for the gut: Microbiota and blood brain barrier. Ann Transl Med. 4:152016.PubMed/NCBI | |
|
Giannopoulou I, Georgiades S, Stefanou MI, Spandidos DA and Rizos E: Links between trauma and psychosis (Review). Exp Ther Med. 26:3862023. View Article : Google Scholar : PubMed/NCBI | |
|
Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG and Krajmalnik-Brown R: Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. SciRep. 9:58212019. | |
|
Rantala MJ, Luoto S, Borraz-Leon JI and Krams I: Schizophrenia: The new etiological synthesis. Neurosci Biobehav Rev. 142:1048942022. View Article : Google Scholar : PubMed/NCBI | |
|
Munawar N, Ahmad A, Anwar MA and Muhammad K: Modulation of gut microbial diversity through non-pharmaceutical approaches to treat schizophrenia. Int J Mol Sci. 23:26252022. View Article : Google Scholar : PubMed/NCBI | |
|
Roth W, Zadeh K, Vekariya R, Ge Y and Mohamadzadeh M: Tryptophan metabolism and gut brain homeostasis. Int J Mol Sci. 22:29232021. View Article : Google Scholar | |
|
Zhu F, Guo R, Wang W, Ju Y, Wang Q, Ma Q, Sun Q, Fan Y, Xie Y, Yang Z, et al: Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol Psychiatry. 25:2905–2918. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Agus A, Planchais J and Sokol H: Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 23:716–724. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ghorbani M, Rajandas H, Parimannan S, Stephen Joseph GB, Tew MM, Ramly SS, Muhamad Rasat MA and Lee SY: Understanding the role of gut microbiota in the pathogenesis of schizophrenia. Psychiatr Genet. 31:39–49. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mikulska J, Juszczyk G, Gawrońska-Grzywacz M and Herbet M: Brain sciences HPA Axis in the pathomechanism of depression and schizophrenia: New therapeutic strategies based on its participation. Brain Sci. 11:12982021. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, Liu Y, Cheng K, Zhou C, Wang H, et al: The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 5:eaau83172019. View Article : Google Scholar : PubMed/NCBI | |
|
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr and Charney DS: Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 51:199–214. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Jodo E: The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: A model for schizophrenia. J Physiol Paris. 107:434–440. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Luqman A, Nega M, Nguyen MT, Ebner P and Götz F: SadA: Expressing staphylococci in the human gut show increased cell adherence and internalization. Cell Rep. 22:535–545. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Luo ZY, Hu YY, Bi YW, Yang JM, Zou WJ, Song YL, Li S, Shen T, Li SJ, et al: The gut microbiota regulates autism-like behavior by mediating vitamin B6 homeostasis in EphB6-deficient mice. Microbiome. 8:1202020. View Article : Google Scholar : PubMed/NCBI | |
|
Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Leweke FM, et al: Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res. 138:48–53. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Severance EG, Gressitt KL, Yang S, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dickerson FB and Yolken RH: Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 16:230–240. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB and Yolken RH: Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res. 148:130–137. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Severance EG, Yolken RH and Eaton WW: Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: More than a gut feeling. Schizophr Res. 176:23–35. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu F, Ju Y, Wang W, Wang Q, Guo R, Ma Q, Sun Q, Fan Y, Xie Y, Yang Z, et al: Metagenome-Wide association of gut microbiome features for schizophrenia. Nat Commun. 11:16122020. View Article : Google Scholar : PubMed/NCBI | |
|
Shen Y, Xu J, Li Z, Huang Y, Yuan Y, Wang J, Zhang M, Hu S and Liang Y: Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study. Schizophr Res. 197:470–477. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Zhuo M, Huang X, Huang Y, Zho J, Xiong D, Li J, Liu Y, Pan Z, Li H, et al: Altered gut microbiota associated with symptom severity in schizophrenia. PeerJ. 8:e95742020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu R, Wu B, Liang J, He F, Gu W, Li K, Luo Y, Chen J, Gao Y, Wu Z, et al: altered gut microbiota and mucosal immunity in patients with schizophrenia. Brain Behav Immun. 85:120–127. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Nguyen TT, Kosciolek T, Maldonado Y, Daly RE, Martin AS, McDonald D, Knight R and Jeste DV: Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects. Schizophr Res. 204:23–29. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nocera A and Nasrallah HA: The association of the gut microbiota with clinical features in schizophrenia. Behav Sci (Basel). 12:892022. View Article : Google Scholar : PubMed/NCBI | |
|
Sen P, Prandovszky E, Honkanen JK, Chen O, Yolken R and Suvisaari J: Dysregulation of microbiota in patients with first-episode psychosis is associated with symptom severity and treatment response. Biol Psychiatry. 95:370–379. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Schwarz E, Maukonen J, Hyytiäinen T, Kieseppä T, Orešič M, Sabunciyan S, Mantere O, Saarela M, Yolken R and Suvisaari J: Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res. 192:398–403. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
He Y, Kosciolek T, Tang J, Zhou Y, Li Z, Ma X, Zhu Q, Yuan N, Yuan L, Li C, et al: Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis. Eur Psychiatry. 53:37–45. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU, Hei G, Lv L, Huang XF, Fan X and Song X: Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia. Schizophr Res. 201:299–306. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Pan LY, Zhang Z, Zhou YY, Jiang HY and Ruan B: Analysis of gut mycobiota in first-episode, drug-naïve Chinese patients with schizophrenia: A pilot study. Behav Brain Res. 379:1123742020. View Article : Google Scholar : PubMed/NCBI | |
|
Ma X, Asif H, Dai L, He Y, Zheng W, Wang D, Ren H, Tang J, Li C, Jin K, et al: Alteration of the gut microbiome in first-episode drug-naïve and chronic medicated schizophrenia correlate with regional brain volumes. J Psychiatr Res. 123:136–144. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu C, Zheng M, Ali U, Xia Q, Wang Z, Chenlong, Yao L, Chen Y, Yan J, Wang K, et al: Association between abundance of haemophilus in the gut microbiota and negative symptoms of schizophrenia. Front Psychiatry. 12:6859102021. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan X, Wang Y, Li X, Jiang J, Kang Y, Pang L, Zhang P, Li A, Lv L, Andreassen OA, et al: Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: A 24-week follow-up study. Transl Psychiatry. 11:4222021. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Fan X, Yuan X, Pang L, Hu S, Wang Y, Huang X and Song X: The role of butyric acid in treatment response in drug-naïve first episode schizophrenia. Front Psychiatry. 12:7246642021. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan X, Li X, Kang Y, Pang L, Hei G, Zhang X, Wang S, Zhao X, Zhang S, Tao Q, et al: Gut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia. Schizophr Res. 250:76–86. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Yuan X, Zhu Z, Pang L, Ding S, Li X, Kang Y, Hei G, Zhang L, Zhang X, et al: Multiomics analyses reveal microbiome-gut-brain crosstalk centered on aberrant gamma-aminobutyric acid and tryptophan metabolism in drug-naïve patients with first-episode schizophrenia. Schizophr Bull. 50:187–198. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
García-Bueno B, Bioque M, Mac-Dowell KS, Barcones MF, Martínez-Cengotitabengoa M, Pina-Camacho L, Rodríguez-Jiménez R, Sáiz PA, Castro C, Lafuente A, et al: Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull. 40:376–387. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
García-Bueno B, Bioque M, MacDowell KS, Santabárbara J, Martínez-Cengotitabengoa M, Moreno C, Sáiz PA, Berrocoso E, Gassó P, Fe Barcones M, et al: Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-upstudy. Int J Neuropsychopharmacol. 18:pyu0372014. View Article : Google Scholar : PubMed/NCBI | |
|
O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF and Dinan TG: Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry. 65:263–267. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Plotsky PM, Thrivikraman KV, Nemeroff CB, Caldji C, Sharma S and Meaney MJ: Long-term consequences of neonatal rearing on central corticotropin releasing factor systems in adult male rat offspring. Neuropsychopharmacology. 30:2192–2204. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ko CY and Liu YP: Isolation rearing impaired sensorimotor gating but increased pro-inflammatory cytokines and disrupted metabolic parameters in both sexes of rats. Psychoneuroendocrinology. 55:173–183. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dunphy-Doherty F, O'Mahony SM, Peterson VL, O'Sullivan O, Crispie F, Cotter PD, Wigmore P, King MV, Cryan JF and Fone KCF: Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis. Brain Behav Immun. 68:261–273. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Morgan C, Charalambides M, Hutchinson G and Murray RM: Migration, ethnicity, and psychosis: Toward a sociodevelop-mental model. Schizophr Bull. 36:655–664. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Davis EG, Humphreys KL, McEwen LM, Sacchet MD, Camacho MC, MacIsaac JL, Lin DTS, Kobor MS and Gotlib IH: Accelerated DNA methylation age in adolescent girls: Associations with elevated diurnal cortisol and reduced hippocampal volume. Transl Psychiatry. 7:e12232017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Li D, Jin W, Shi Y, Li Z, Ma P, Sun J, Chen S, Li P and Lin P: Research progress on the correlation between epigenetics and schizophrenia. Front Neurosci. 15:6887272021. View Article : Google Scholar : PubMed/NCBI | |
|
Alameda L, Rodriguez V, Carr E, Aas M, Trotta G, Marino P, Vorontsova N, Herane-Vives A, Gadelrab R, Spinazzola E, et al: A systematic review on mediators between adversity and psychosis: Potential targets for treatment. Psychol Med. 50:1966–1976. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bayer TA, Falkai P and Maier W: Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the ‘two hit hypothesis.’. J Psychiatr Res. 33:543–548. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Charmandari E, Kino T, Souvatzoglou E and Chrousos GP: Pediatric stress: Hormonal mediators and human development. Horm Res. 59:161–179. 2003.PubMed/NCBI | |
|
Lardinois M, Lataster T, Mengelers R, Van Os J and Myin-Germeys I: Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiatr Scand. 23:28–35. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Walker EF, Brennan PA, Esterberg M, Brasfield J, Pearce B and Compton MT: Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. J Abnorm Psychol. 119:401–408. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, et al: Cortisol levels and risk for psychosis: Initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 74:410–417. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 57:925–935. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Vita A, De Peri L, Silenzi C and Dieci M: Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res. 82:75–88. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Thompson Ray M, Weickert CS, Wyatt E and Webster MJ: Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippo-campus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci. 36:195–203. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Daskalakis NP, De Kloet ER, Yehuda R, Malaspina D and Kranz TM: Early life stress effects on Glucocorticoid-BDNF interplay in the hippocampus. Front Mol Neurosci. 8:682015. View Article : Google Scholar : PubMed/NCBI | |
|
Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, Gournellis R and Lykouras L: Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 32:1308–1311. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rizos EN, Papathanasiou M, Michalopoulou PG, Mazioti A, Douzenis A, Kastania A, Nikolaidou P, Laskos E, Vasilopoulou K and Lykouras L: Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophr Res. 129:201–204. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Rizos EN, Michalopoulou PG, Siafakas N, Stefanis N, Douzenis A, Rontos I, Laskos E, Kastania A, Zoumpourlis V and Lykouras L: Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia. Neuropsychobiology. 62:87–90. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, et al: Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis. Schizophr Res. 159:56–61. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ghaderi A, Banafshe HR, Mirhosseini N, Moradi M, Karimi MA, Mehrzad F, Bahmani F and Asemi Z: Clinical and metabolic response to vitamin D plus Probiotic in schizophrenia patients. BMC Psychiatry. 19:772019. View Article : Google Scholar : PubMed/NCBI | |
|
Okubo R, Koga M, Katsumata N, Odamaki T, Matsuyama S, Oka M, Narita H, Hashimoto N, Kusumi I, Xiao J and Matsuoka YJ: Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. J Affect Disord. 245:377–385. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J and Cryan JF: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 108:16050–16055. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kao ACC, Spitzer S, Anthony DC, Lennox B and Burnet PWJ: Prebiotic attenuation of olanzapine-induced weight gain in rats: Analysis of central and peripheral biomarkers and gut microbiota. Transl Psychiatry. 8:662018. View Article : Google Scholar : PubMed/NCBI | |
|
Hinton R: A case report looking at the effects of faecal microbiota transplantation in a patient with bipolar disorder. Aust N Z J Psychiatry. 54:649–650. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Parker G, Spoelma MJ and Rhodes N: Faecal microbiota transplantation for bipolar disorder: A detailed case study. Bipolar Disord. 24:559–563. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Patrono E, Svoboda J and Stuchlík A: Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis. Behav Brain Funct. 17:72021. View Article : Google Scholar : PubMed/NCBI | |
|
Nuncio-Mora L, Lanzagorta N, Nicolini H, Sarmiento E, Ortiz G, Sosa F and Genis-Mendoza AD: The role of the microbiome in first episode of psychosis. Biomedicines. 11:17702023. View Article : Google Scholar : PubMed/NCBI | |
|
Aschner M, Skalny AV, Gritsenko VA, Kartashova OL, Santamaria A, Rocha JBT, Spandidos DA, Zaitseva IP, Tsatsakis A and Tinkov AA: Role of gut microbiota in the modulation of the health effects of advanced glycation end-products (Review). Int J Mol Med. 51:442023. View Article : Google Scholar : PubMed/NCBI | |
|
Tsamakis K, Galinaki S, Alevyzakis E, Hortis I, Tsiptsios D, Kollintza E, Kympouropoulos S, Triantafyllou K, Smyrnis N and Rizos E: Gut Microbiome: A brief review on its role in schizophrenia and first episode of psychosis. Microorganisms. 10:11212022. View Article : Google Scholar : PubMed/NCBI |
